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Assessing the relationship of exposure to environmental tobacco smoke (ETS) with subclinical
measures of atherosclerotic disease supplements the epidemiologic data on fatal and nonfatal
cardiovascular events. In addition, such assessment offers the opportunity to study smaller
populations (including subgroups within larger studies) through improved statistical precision relative
to the analysis of the relationship of ETS and clinical events and provides insights into the
mechanisms of the harmful effects of ETS. In this article we review the published literature on the
relationship of ETS with several indices of subclinical atherosclerosis including carotid artery
intimal-medial thickness, brachial artery endothelial functioning, and silent cerebral infarctions. In
each of these domains, exposure to ETS is associated with evidence of increased subclinical
vascular disease. Key words: atherosclerosis, carotid arteries, cerebral infarction, Duplex
ultrasonography, smoking, tobacco smoke pollution, vascular endothelium. - Environ Health
Perspect 107(suppl 6):837-840 (1999).
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Background
Numerous case-control and cohort studies
have established exposure to environmental
tobacco smoke (ETS) as a substantial risk
factor for the development of clinical coro-
nary events associated with increases of
1.2-1.5 times the risk of those not exposed
to ETS (1,2). The findings of case-control
studies are subject to specific methodologic
concerns, especially information bias. These
case-control studies are, however, supported
by prospective cohort studies, such as the
American Cancer Society CPS-II cohort (3)
and the Nurses' Health Study (4), that pro-
vide additional information of the associa-
tion ofETS and clinical coronary disease and
allow for adjustment for potential confound-
ing factors. A strength of the epidemiologic
data is that studies using different designs
(prospective and retrospective, cohort and
case-control) in different countries find
generally similar results.
Because of the established association of
ETS with clinical cardiovascular events (1-4),
the role ofestablishing associations between
ETS and subclinical disease may appear illogi-
cal. However, the link between ETS and sub-
clinical disease is important for at least three
reasons. First, even in the large cohort studies,
the number of events is relatively small. For
example, the Nurses Health Study with
32,046 participants only presented with 152
clinical coronary events (4). This small num-
ber of events limits the statistical power to
examine more complex hypotheses, relation-
ships in subgroups, and the potential for effect
modification. Many measures of subclinical
disease offer increased statistical power, either
by providing a continuous (rather than
dichotomous or time-to-event measure) out-
come measure or by increasing the number of
events (by including Asilent events). Second,
analysis ofsubclinical disease outcomes offers
insight into the mechanisms underlying the
development ofclinical coronary events. And
finally, analysis ofsubclinical outcomes allows
an assessment ofthe natural history ofthe dis-
ease process, particularly the early phases. This
is an advantage over a study ofthe final clini-
cal events that generally manifest at older ages,
not only by providing an index ofthe effect of
factors at younger ages but also by avoiding
potential biases associated with selective mor-
tality and ascertainment (or response) bias
(which may result from knowledge of a
clinical condition).
There are several mechanistic pathways
through which exposure to ETS could affect
the development of(subclinical) atherosclero-
sis. The article by Glantz and Parmley (5)
summarizes the potential pathways that a)
compromise the myocardium's ability to use
oxygen to create adenosine triphosphate that
may in turn increase arterial stress, b) increase
platelet activity with associated direct impact
on atherosclerotic plaque development, and
(3) decrease endothelial function. These effects
are observed in people exposed to ETS in
"normal" smoke-filled homes andworkplaces.
For all these reasons, there has been
growing interest in analysis ofsubclinical dis-
ease in cardiovascular epidemiology.
Commonly used subclinical outcomes
include a) assessment of the intimal medial
thickness (IMT) ofthe carotid artery using B-
mode real-time ultrasound, as an index ofsys-
temic atherosclerosis; b) assessment ofarterial
endothelial function using B-mode ultra-
sound of the brachial artery, as an index of
vascular damage; c) assessment of the
presence of silent cerebral infarctions and
cortical white matter disease using magnetic
resonance imaging; d) assessment of the
presence ofcoronary arterial calcium using
electron beam-computed tomography scan-
ning, as an index ofcoronary atherosclerosis;
and e) measurement ofblood pressure in the
ankle, compared to that in the arm, as an
index ofperipheral vascular disease (6). These
measures ofsubclinical disease are powerful
predictors of subsequent incident cardio-
vascular events. For example, increased IMT is
associated with substantial increased risk of
incidentcoronaryevents (details follow) (7-9),
andsubclinical infarctions have been associated
with an increase in the risk ofincident stroke
as large as that associated with a clinically pro-
nounced stroke (10). In this article, we review
the literature on ETS and selected measures of
subclinical cardiovascular disease.
Carotid Ultrasonography
B-mode real-time ultrasound can be used to
assess noninvasively the extent of athero-
sclerosis in arteries close to the skin surface.
The carotid artery has received particular
attention, initially for its relevance to stroke
events. The strong association has been well
established between active smoking and
advanced atherosclerosis in stroke popula-
tions (11,12) and in some populations is the
strongest single predictor ofatherosclerosis in
clinical populations (13).
The Atherosclerosis Risk in Communities
(ARIC) study was among the first epidemio-
logic studies to use the IMT of the carotid
artery as an index ofsystemic atherosclerosis
in a population-based study of the general
population (14). Studies have established
that IMT is related to the extent and severity
of coronary artery disease (p < 0.0001).
However,the strength of the association
between carotid and coronary disease is not
sufficient so that knowledge ofcarotid status
can reliably predict the coronary status for a
specific individual (15). That the correlation
is not sufficient for predictive use in individu-
als is not ofparticular concern, as the focal
nature of atherosclerotic plaques leads to
relatively low correlations even between sites
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in the carotid bed (16). That is, the systemic
nature ofatherosclerosis presents a strong
association between arterial beds, but the
focal nature ofplaques prevents direct clinical
prediction between sites for an individual.
Perhaps the most convincing evidence ofthe
relevance ofIMT as an index ofsystemic ath-
erosderosis is its strong association with subse-
quent clinical events (7-9). In the ARIC
study, those female participants with IMTs
greater than 1,000 pmwere atapproximately 5
times the riskofsubsequent myocardial infarc-
tion compared to those with IMTs less than
1,000 pm, whereas men with IMTs greater
than 1,000 pm were at twice the risk (7).
Similarly, the Rotterdam study also showed a
41% increase in stroke riskand a43% increase
in risk for a subsequent myocardial infarction
(p < 0.0001 for both) associated with a stan-
dard deviation increase in IMT (163 pm) (8).
Thickened IMT was also associated with
increased risk for coronary events in the
Cardiovascular Health Study, where the rela-
tive risk ofmyocardial infarction or stroke
(adjusted for age and sex) for the quintile with
the highest thickness was approximately 4
times greater than that ofthe lowest quintile.
This association remained significant after
adjustment forriskfactors (9).
The ARIC study provides strong evidence
ofincreased IMT with increasing exposure to
cigarette smoke and for exposure to ETS in
particular. In cross-sectional analysis ofdata
from the baseline ARIC visit, there was an
11-pm difference in the average IMT ofnon-
smokers not exposed to ETS (N-E) and non-
smokers exposed to ETS (N+E). This
estimated difference was increased (17 pm)
by adjustment for age, race, and gender (ETS
smokers were younger and more likely to be
female, both associated with thinner IMT
measures), a difference that proved highly sta-
tistically significant (p < 0.0001). This differ-
ence was reduced to 13 pm but remained
statistically significant (p = 0.0027) by further
adjustment for the presence of diabetes,
hypertension, low-density lipoprotein choles-
terol level, education (surrogate for socioeco-
nomic level), fat intake (Keys score), alcohol
intake, obesity (body mass index), and
leisure-time physical activity. As such, the
ARIC study provides dear cross-sectional evi-
dence for an association ofETS with systemic
atherosderosis that is not explained by poten-
tial confounders. Although not directly perti-
nent to this discussion, the IMT measures for
past and current smokers were greater than
those ofnonsmokers (17).
Although exposure to ETS is frequently
lifelong, complete and accurate assessment of
lifetime exposure to ETS is beyond the scope
of most population-based epidemiologic
studies. As such, these studies usually resort to
assessment and analysis ofcurrent measures of
ETS exposure. A notable exception to this
limitation in the assessment ofassociation of
ETS and IMT is the report by Diez-Roux et
al. (18). This study assessed current exposure
to ETS in a cohort of2,073 individuals who
were subsequently included in the ARIC
study. This subsequent ARIC assessment
occurred 12-14 years after the initial assess-
ment and included both evaluations ofETS
exposure as well as an assessment ofIMT. As
such, data were available on exposure to ETS
at two time points separated by 12-14 years
and an ultrasound assessment of athero-
sclerosis at the later point, allowing analysis of
the effect ofboth current and past ETS expo-
sure with the current extent ofatherosclerosis.
Diez-Roux et al. (18) defined four groups of
participants in this study: those notexposed to
ETS at either exam, those exposed at the first
but not the second exam, those exposed at the
second but not the first, and those exposed at
both exams. Exposure to ETS in one or both
periods was associated with increased IMT by
a nearly identical amount, suggesting long-
term harmful effects ofETS exposure (beyond
current exposure). The average IMT ofthose
not exposed in either period was 706 pm;
those exposed in the first period only, 731
lpm; those exposed in the second period only,
738 pm; and those exposed in both periods,
734 pm. As such, this study reflects the harm-
ful effects ofonly historical ETS exposure,
which are approximately the same as the effect
ofexposure concurrently with the assessment
ofatherosclerosis.
The cross-sectional association oflarger
IMT with greater exposure to cigarette smoke
is consistent with previously unpublished
results from the Insulin Resistance
Atherosclerosis Study (IRAS). The design and
methods for this population-based epidemio-
logic study have been reported elsewhere
(19). Briefly summarized, 1,625 participants
were evaluated in four clinical centers, with
detailed assessment ofIMT, smoking history,
and potential confounders. The average IMT
was estimated in this population for N-E,
N+E, past smokers not exposed to ETS
(P-E), past smokers exposed to ETS (P+E),
and current smokers (C) after adjustment for
age, ethnicity, sex, obesity (body mass index),
hypertension, low-density and high-density
lipoprotein levels, triglyceride levels, diabetes
status, alcohol intake, socioeconomic status
(indexed by education), and physical activity
(indexed by total energy expenditure). In the
common carotid artery, there was a step-wise
relationship with increasing exposure to ciga-
rette smoke from 810 pm for N-E, to 813
pm for N+E, to 829 pm for P-E, to 845 pm
for P+E, and finally to 863 pm for C. In the
internal carotid artery the relationship was
reversed for N-E (881 pm) and N+E
(864 pm) but was otherwise ordered from
892 pm for P-E, to 939 pm for P+E, and
finally 990 pm for C. Other large epidemio-
logic studies addressing the relationship of
smoking and IMT have addressed only the
impact ofactive smoking and have failed to
provide a description ofthe effect of ETS
(20-22).
In addition to the cross-sectional
association between ETS and IMT, theARIC
study also examined longitudinal association
between exposure to ETS and the progression
(worsening) ofatherosclerosis (23). In a lon-
gitudinal analysis, exposure (in this case ETS)
is assessed prior to the determination ofthe
outcome (worsening of atherosclerosis),
thereby avoiding concerns ofthe temporal
sequencing of the exposure and outcome.
After adjustment for age, race, sex, baseline
IMT, hypertension, low-density lipoprotein
levels, previous coronary heart disease, dia-
betes, dietary fat intake (Keys score), socio-
economic status (education), leisure-time
physical activity, and alcohol use, the esti-
mated progression rate for N-E was 25.9 pm
over a 3-year follow-up compared to 31.6 pm
for N+E, 32.8 pm for P-E, 38.8 pm for P+E,
and 43.0 pm for C. The average increase in
progression rate associatedwith ETS exposure
(across nonsmokers and past smokers) was
5.9 ± 2.3 pm over a 3-year period (a 20%
increase), adifference thatwas statistically sig-
nificant (p = 0.01). In addition, subgroups of
the population were identified as particularly
susceptible to increased exposure to cigarette
smoke. Specifically, the magnitude of the
increase in progression rate associated with
exposure to cigarette smoke (either active or
ETS) was approximately twice the increases
observed among nondiabetic subjects. The
average progression ofatherosclerosis among
participants with hypertension also appeared
to be at a faster rate than that of their
normotensive counterparts.
These data, largely reflecting the results of
the ARIC study, indicate that exposure to
ETS is associatedwith greater levels and faster
progression of atherosclerosis, indicating a
potential mechanism of the association of
ETS and clinical coronary events.
Endothelial Function
Endothelial damage has been hypothesized to
be one of the early steps in the process of
atherogenesis and is likely to be an important
early marker of vascular damage (24).
Endothelial function can be assessed bymeas-
uring the dilatation ofthe brachial artery fol-
lowing hyperemia ofthe forearm induced by
a pneumatic tourniquet (25).
Celemajer et al. (26) have reported the
association ofendothelial function and expo-
sure to cigarette smoke in 26 N-E, 26 N+E,
and 26 C. These groups did not differ by age,
gender, blood pressure, cholesterol, or vessel
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size. The flow-mediated percent dilation of
the N-E was 8.2 ± 3.1, which was substan-
tially greater than that of the N+E (3.1 ±
2.7%). The dilation for N+E was even non-
significantly less than that ofC (4.4 ± 3.1%),
a group previously shown to have substan-
tially impaired endothelial function (27).
Finally, among the N+E, there was a clear
dose-response relationship with increasing
exposure to ETS, with those with light expo-
sure (1-3 hr/day) showing a 4.1 ± 2.2%
response compared to a 3.1 ± 2.2% response
among those with moderate exposure (4-6
hr/day) and a 1.8 ± 2.0% response among
those with heavy exposure (more than 6
hr/day). Woo et al. (28) have reported similar
results among Caucasians in Australia and
England but found no association between
smoking (active or ETS) and endothelial
function in a Chinese population.
Hence, at least in Caucasian populations,
there appears to be an association between
ETS exposure and endothelial function, an
early indicator ofarterial damage.
Silent Cerebral lnfarctions
The advent ofwidespread magnetic resonance
imaging capability allows the assessment of
silent cerebral infarctions (SCIs) to be
extended from neurologic patients to
population-based cohorts. Between 10 and
40% of patients with transient ischemic
attacks have SCIs (29), and in neurologic
populations the prognosis for patients with
SCIs is suggested to be nearly as poor as for
thosewith clinically manifest strokes (10).
The association between cigarette
smoking, ETS exposure, and the presence of
SCIs in the general population was recently
evaluated in the ARIC study (30). Overall,
11% ofthis middle-age population has silent
cerebral infarctions. Cigarette smoking was
among the most powerful predictors ofpreva-
lent SCIs. Current smokers had an 88%
increase in the risk ofSCIs after control for
age, race, sex, hypertension, diabetes, high-
density lipoprotein and triglyceride levels,
alcohol use, obesity (body mass index),
leisure-time physical activity, and dietary fat
intake (Keys score). Past smokers have a 16%
increase in the risk ofprevalent SCIs. ETS
exposure was also studied. Compared to the
N-E group, the N+E group has a 6%
increase (p > 0.05) in the likelihood ofSCIs.
The overall trend for increased risk of SCIs
with increased exposure to cigarette smoke
provedstatisticallysignificant (p = 0.029).
Other Measures of Subclinical
Disease
To our knowledge there is no literature on or
analysis ofthe relationship ofETS with other
important measures ofsubclinical disease such
as measures of peripheral vascular disease,
coronary calcium by electron beam-computed
tomography, or left ventricular function by
echocardiogram or electrocardiogram. Clearly,
further research is needed on ETS and other
measures ofsubclinical disease.
Summary
The association of ETS with subclinical
indices ofatherosclerosis is based largely on
associations observed in the ARIC popula-
tion. In atherosclerosis, theARIC data appear
to strongly support an association in both
cross-sectional and longitudinal analyses.
However, this association is supported by
previously unreported data (and non-peer-
reviewed) reported here from the IRAS
study. Although the association ofETS expo-
sure and IMT thickening is based largely on
the ARIC study, the strength ofthe associa-
tion and its persistence in both cross-sec-
tional and longitudinal analysis augment
other evidence that ETS exposure causes car-
diovascular injury. Similarly, the association
ofETS with endothelial function is strongly
supported by the magnitude ofits effect and
the existence of a dose-response function
within the N+E group. The association of
ETS with SCIs is weaker (a nonsignificant
6% increase in risk). However, the effect is in
the anticipated direction and is consistent
with the pattern ofeffects observed for ather-
osclerosis ofthe carotid artery. Although evi-
dence ofan ETS effect on atherosclerosis and
endothelial function appears strong, it is
based on a single report; confirmation would
substantially strengthen the argument for the
existence of an effect. More important, sig-
nificant other domains ofsubclinical disease
remain unaddressed.
Using subclinical measures of
atherosclerosis to assess the relationship of
ETS exposure and atherosclerosis does not
address the most challenging aspect of the
assessment ofrisk associated with ETS-the
assessment ofthe exposure itself. One major
shortcoming ofthese reports is the possibility
ofmisclassification bias when assessing ETS,
particularly over the lifetime of those
exposed. In addition, the widespread nature
ofETS exposure makes it difficult to ensure
the nonexposure of the reference group.
However, these shortcomings should, on
average, tend to make the identification ofan
association more difficult (i.e., bias toward
the null hypothesis ofno association).
In relatively small populations, subclinical
measures of atherosclerosis can be used to
establish an association with ETS. For exam-
ple, a relationship between ETS exposure and
endothelial functioning using only 52 sub-
jects (26), a slight increase in the prevalence
of SCIs associated with ETS exposure with
only 1,737 subjects (30), and a difference in
progression rates of carotid atherosclerosis
were established between 4,298 participants
exposed to ETS and 3,660 not exposed (23).
This is in contrast to the substantial studysize
that would be required to establish an associa-
tion of ETS with incident clinical events.
Specifically, the optimal prospective study
design (smallest sample size) would be to fol-
low a population of never smokers with a
50% exposure to ETS for incident events. If
the anticipated hazard ratio associated with
ETS exposure were 1.3, then a population of
sufficient size to provide 611 incident events
would be required to provide even 80%
power (31). In Framingham, Massachusetts,
the risk ofa heart attack in an 8-year period
was 47/1,000 in men and 8/1,000 in women
(32). In a population that is 50% female, this
corresponds to an annual incidence rate of
approximately 0.3%. At this incidence rate, a
total of 203,667 person-years of exposure
would be required to provide 611 events,
clearly asubstantial undertaking.
The differences in subclinical measures of
atherosderosis aresmall between those individ-
uals exposed to ETS and those not exposed.
However, the long-term clinical impact of
such small differences in subclinical measures
ofatherosclerosis has been established. Such
small differences in IMT ofthe carotid artery
are powerful and independent predictors of
new coronary heart disease events (7-9), and
subclinical infarctions have been associated
with an increase in the risk ofincident stroke
as large as that associated with a clinically pro-
nounced stroke (10). As such, although these
associations should be interpreted with cau-
tion, they suggest that a higher cardiovascular
risk is associated with ETS exposure.
Additional work to assess the relationship of
ETS with other indices of subclinical
atherosderosis should beencouraged.
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